Supplement Scholar
Herb

Curcumin

Buy on Amazon ↗

Affiliate link: we may earn a commission at no extra cost to you. Disclosures

Curcumin. Yellow polyphenol from turmeric — anti-inflammatory and joint-supportive when properly bioavailable.

How it works. Inhibits NF-κB activation, COX-2, 5-LOX, and multiple inflammatory cytokines.

What the research supports. 3 graded claims. Strongest: Reduces osteoarthritis pain (comparable to NSAIDs in some trials) (moderate).

How much to take. Typical dose: 500–1,000 mg/day bioavailability-enhanced curcumin. With meals containing fat.

Side effects and interactions. 3 medication interactions listed. Serious: Rare hepatotoxicity reports (especially with piperine + high doses).

Stacking. Pairs well with Omega-3, Black pepper (piperine, 5–20 mg). Avoid combining with Pre-surgery (2 weeks before).

Forms. 2 forms. Pick one to open its profile.

Key studies. 10 studies cited. The strongest are listed with links to PubMed.

Community. Experiences from people who have tried Curcumin. Anecdotes are not medical advice.

Curcumin. Yellow polyphenol from turmeric — anti-inflammatory and joint-supportive when properly bioavailable.

Key compound: curcuminC21H20O6 · 368.4 g/mol

What it is

The principal curcuminoid in turmeric root. Poorly absorbed in its native form — bioavailability-enhanced formulations (Meriva, BCM-95, Theracurmin) are required for clinical effect.

Also called

Turmeric extract

Food sources

Turmeric root (~3–5% curcumin)

Goals

How it works

Inhibits NF-κB activation, COX-2, 5-LOX, and multiple inflammatory cytokines.

Pathways

  • NF-κB inhibition
  • COX-2 / 5-LOX inhibition
  • Nrf2 activation

Effects

  • ↓Systemic inflammation (hs-CRP) decreases
  • ↓Joint pain and stiffness decreases
  • +Endothelial function supports

What the research supports

Reduces osteoarthritis pain (comparable to NSAIDs in some trials)moderate
Reduces systemic inflammation markersmoderate
Reduces depression symptoms (adjunctive)limited

Strong: consistent results across large trials or meta-analyses. Moderate: several trials, mostly positive. Limited: small or mixed studies. Preclinical: animal or cell research only.

Typical dose
500–1,000 mg/day bioavailability-enhanced curcumin
TimingWith meals containing fat
With foodWith food — fat-soluble
Best formMeriva, BCM-95, or Theracurmin for absorption
Upper limitNot formally defined; up to 8 g/day shown tolerable
Shop Curcumin on Amazon ↗

As an Amazon Associate I earn from qualifying purchases. Look for USP, NSF or Informed Sport seals before you buy.

Side effects & interactions

Common side effects

  • Mild GI upset
  • Yellow stool

Serious

  • Rare hepatotoxicity reports (especially with piperine + high doses)

Medication interactions

Anticoagulantsmoderate

Mild antiplatelet activity.

Anti-diabeticsminor

May additively lower glucose.

CYP3A4 substrates (with piperine)moderate

Piperine strongly inhibits CYP3A4.

Check any supplement–medication combination with your pharmacist before starting.

Combines with

Pairs well

  • Omega-3Complementary anti-inflammatory pathways.
  • Black pepper (piperine, 5–20 mg)Increases curcumin bioavailability ~20x.

Avoid combining

  • Pre-surgery (2 weeks before)Antiplatelet effect.

Key studies

10 studies cited in total.

PubMed: Curcumin — Reduces osteoarthritis pain ↗
Systematic review · PubMed (NLM) · 2026

Opens current human and preclinical literature matching Curcumin and "Reduces osteoarthritis pain". Filter by RCT, meta-analysis, or year on the results page.

PubMed: Curcumin — Reduces systemic inflammation markers ↗
Systematic review · PubMed (NLM) · 2026

Opens current human and preclinical literature matching Curcumin and "Reduces systemic inflammation markers". Filter by RCT, meta-analysis, or year on the results page.

PubMed: Curcumin — Reduces depression symptoms ↗
Systematic review · PubMed (NLM) · 2026

Opens current human and preclinical literature matching Curcumin and "Reduces depression symptoms". Filter by RCT, meta-analysis, or year on the results page.

Discussion

Loading discussion…